2.79
-0.03(-1.06%)
Currency In USD
| Previous Close | 2.82 |
| Open | 2.81 |
| Day High | 2.84 |
| Day Low | 2.78 |
| 52-Week High | 3.05 |
| 52-Week Low | 1.54 |
| Volume | 315,040 |
| Average Volume | 507,603 |
| Market Cap | 252.44M |
| PE | -9.62 |
| EPS | -0.29 |
| Moving Average 50 Days | 2.55 |
| Moving Average 200 Days | 2.22 |
| Change | -0.03 |
If you invested $1000 in Stereotaxis, Inc. (STXS) 10 years ago, it would be worth $2,513.51 as of September 16, 2025 at a share price of $2.79. Whereas If you bought $1000 worth of Stereotaxis, Inc. (STXS) shares 5 years ago, it would be worth $685.5 as of September 16, 2025 at a share price of $2.79.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
GlobeNewswire Inc.
Sep 02, 2025 12:08 PM GMT
ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the successful completion of the world’s first procedures usi
Stereotaxis to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Sep 02, 2025 11:51 AM GMT
ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will present at two inv
Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025
GlobeNewswire Inc.
Aug 28, 2025 11:47 AM GMT
ST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its technology will be featured during the upcoming HRX digita